Caleres (CAL) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
11 Dec, 2025Executive summary
Consolidated sales rose 6.6% year-over-year to $790.1 million, driven by Brand Portfolio growth and the Stuart Weitzman acquisition, while Famous Footwear sales declined 2.2%.
Lead brands achieved double-digit organic growth, with international sales up over 30% and eCommerce sales rising double digits across both segments.
Stuart Weitzman contributed $45.8 million in Q3 sales; integration is underway with a focus on cost synergies and break-even targeted for 2026.
Direct-to-consumer sales accounted for 71% of Q3 net sales.
GAAP EPS dropped to $0.07 from $1.19; adjusted EPS was $0.38, or $0.67 excluding Stuart Weitzman.
Financial highlights
Q3 net sales: $790.1 million, up 6.6% year-over-year; Brand Portfolio up 18.8%, Famous Footwear down 2.2%.
Gross profit: $329.9 million; gross margin 41.8%, down 230 bps; adjusted gross margin 42.7%, down 140 bps.
Adjusted operating earnings: $26.3 million (3.3% of sales); adjusted EPS $0.38, or $0.67 excluding Stuart Weitzman.
Inventory at $678 million, up $92 million year-over-year, with $77 million from Stuart Weitzman.
Borrowings under revolving credit facility: $355 million; liquidity: $312 million.
Outlook and guidance
Q4: Famous Footwear comp sales expected flat, total sales down low single digits; Brand Portfolio sales expected flat to up 1% organically, with Stuart Weitzman to add $55–$60 million.
Full-year adjusted EPS guidance: $0.55–$0.60 including Stuart Weitzman, $1.15–$1.25 excluding; full-year GAAP loss per share of $(0.13) to $(0.18).
Stuart Weitzman expected to be dilutive in 2025, with break-even targeted for 2026.
Consolidated gross margin expected down 75–100 bps; full-year tax rate projected at 27% to 28%.
Expense reduction initiatives projected to lower SG&A by $15 million annually.
Latest events from Caleres
- Sales down 1.8% as ERP disruptions and weak demand led to lower results and revised guidance.CAL
Q2 202520 Jan 2026 - Q3 sales fell 2.8% to $740.9M, with lower earnings but market share gains and strong buybacks.CAL
Q3 202511 Jan 2026 - FY24 met guidance; FY25 outlook cautious with Stuart Weitzman acquisition and sourcing shift.CAL
Q4 202526 Dec 2025 - Disciplined management, strong brands, and robust governance position the company for future growth.CAL
Proxy Filing1 Dec 2025 - Shareholders to vote on directors, executive pay, and auditor ratification at annual meeting.CAL
Proxy Filing1 Dec 2025 - Sales and earnings fell, but market share gains and cost-saving actions provide optimism.CAL
Q1 202626 Nov 2025 - Lead brands, DTC growth, and cost savings drive performance amid tariff challenges.CAL
2025 Global Consumer & Retail Conference8 Oct 2025 - Q2 sales fell 3.6% as margin pressures persisted, but cost savings and liquidity improved.CAL
Q2 20269 Sep 2025